News
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
TeamSense reports unplanned absences cost American businesses $600B annually, highlighting patterns to help manage ...
Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...
TeamSense reports unplanned absences cost American businesses $600B annually, highlighting patterns to help manage ...
Flu vaccine as high as 59% effective for children 6 months to 8 years old: CDC The flu and pneumonia are now killing nearly 4,000 Americans each week, according to health official ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results